Skip to main content

Novartis’ tislelizumab shows promising survival results in advanced esophageal cancer, Phase 3 data reveals

https://www.financialexpress.com/healthcare/pharma-healthcare/novartis-tislelizumab-shows-promising-survival-results-in-advanced-esophageal-cancer-phase-3-data-reveals/2578524/

AUDIENCES

SUBJECTS

Disclaimer: This information is for educational purposes only, It is not to diagnose or treat your disease. If you do use the information contained on this web site without the approval of a health professional, you are prescribing for yourself, which is your constitutional right, but the author(s) and webmaster assume no responsibility

© 2024 Esophageal Cancer Education Foundation- by domino